🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseSurvodutide MASH Phase 2b — March 2026 Page 7

Survodutide MASH Phase 2b — March 2026

CanadaChris Fri, Aug 15, 2025 at 9:27 PM 31 replies 1,956 viewsPage 7 of 7
cory_ATX
Member
456
2,123
Jul 2024
Austin, TX
Sep 3, 2025 at 5:03 AM#31
Dr.SportsMedIN said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Adding the part of the answer the thread has not reached. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

37 10Dr.EndoEP, GraceAZ_72, carl_compliance and 34 others
Reply Quote Save Share Report
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
Sep 4, 2025 at 1:38 PM#32

Adding the numbers, since they settle part of this. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

I would rather be corrected than agreed with, if it comes to it.

38 11AmyNC_wife, SkepticalSean, Dr.CardioMD and 35 others
Reply Quote Save Share Report
greg_boulder
Member
345
1,567
Jul 2024
Boulder, CO
Sep 5, 2025 at 10:12 PM#33

A narrower follow-up, since the general answer is now clear:

Was that from a primary source or from a summary of one?

Last edited: Sep 6, 2025 at 12:12 AM
39 12Dr.DermMIA, fiona_VT, denise_HTX and 36 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
BariatricNurseD
Senior Member
1,678
7,234
Feb 2024
Dallas, TX
Online
Sep 7, 2025 at 6:45 AM#34
dan_philly said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Pushing back on dan_philly here. I would resist the confidence. Half of what this board was certain about two years ago has since been quietly dropped, and nobody went back to correct the threads.

40 13tom_AK, josh_phd_bmore, roxy_nash and 37 others
Reply Quote Save Share Report
Dr.GastroMayo
VIP Member
2,345
13,456
Jan 2024
Mayo Clinic, MN
Sep 8, 2025 at 3:17 PM#35
dan_philly said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

True, and it depends on a baseline nobody has stated. Without knowing where someone started, the same number can be an excellent result or a disappointing one.

Last edited: Sep 8, 2025 at 8:17 PM
41 14InsuranceTom, WendyG_ATL, SaraMom3 and 38 others
Reply Quote Save Share Report
1567

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register